首页 > 最新文献

International Journal of Cancer Care and Delivery最新文献

英文 中文
INTEGRATION OF PALLIATIVE CARE INTO MEDICAL SCHOOL CURRICULUM IN NEPAL – An analytical study among medical students in Nepal 将姑息治疗纳入尼泊尔医学院课程——尼泊尔医学生的分析研究
Pub Date : 2023-01-26 DOI: 10.53876/001c.68021
Carlotta Bellon, T. Shah, A. Shah
The holistic approach of palliative care aims at improving the life of patients with life-threatening diseases and their families through early identification, assessment, and treatment of physical, psychological, or spiritual pain. Despite the recognition of palliative care as a human right and essential for the improvement of the quality of life of patients – and their families, many low-income countries either lack palliative care services or have limited access to it. The WHO suggests that one of the steps that countries can take to eliminate these barriers is to include palliative care into the core curricula of all new health professionals. A study in 2019 showed that 58,000 adults required palliative care in Nepal in 2012, and most of them lived in rural areas. Palliative care in Nepal is still new and training programs for doctors and nurses are not fully developed and in place in undergraduate medical schools. This study evaluates the working knowledge of palliative care among undergraduate medical students, and the presence of it in their academic curriculum. This analytical study was designed during an internship at the Binaytara Foundation Cancer Center in Nepal. The study was conducted among undergraduate medical students between March 6th, 2020 to July 6th, 2020. The questionnaire results were entered on Microsoft Excel and then analyzed. Results showed that 63.2% of the respondents had heard of “Palliative Medicine”, but 68.4% did not know the WHO definition of Palliative Care (Table 2 (135189)). Among all the students from the different universities, 33.3% said that palliative care is part of their curriculum, while 66.6% said it is not (Table 5 (135192)). The results from the study demonstrated inadequate knowledge and perception of palliative care among undergraduate medical students in Nepali institutions. The EAPC indications on a palliative care curriculum could be taken as a blueprint for developing a tailored one for medical schools in Nepal to set a strong base for the next generation of doctors to be able to appropriately meet the needs of patients and their families.
姑息治疗的整体方法旨在通过早期识别、评估和治疗身体、心理或精神上的痛苦,改善患有危及生命的疾病的患者及其家属的生活。尽管人们承认姑息治疗是一项人权,对改善患者及其家属的生活质量至关重要,但许多低收入国家要么缺乏姑息治疗服务,要么获得这种服务的机会有限。世卫组织建议,各国为消除这些障碍可采取的步骤之一是将姑息治疗纳入所有新卫生专业人员的核心课程。2019年的一项研究显示,2012年尼泊尔有5.8万名成年人需要姑息治疗,其中大多数人生活在农村地区。尼泊尔的姑息治疗仍然是新兴的,医生和护士的培训项目还没有完全开发出来,也没有在本科医学院到位。本研究旨在评估医学生对缓和疗护的工作知识,以及缓和疗护在医学生学术课程中的存在。这项分析性研究是在尼泊尔Binaytara基金会癌症中心实习期间设计的。该研究于2020年3月6日至2020年7月6日在医科本科生中进行。将问卷结果输入到Microsoft Excel中进行分析。结果显示,63.2%的受访者听说过“姑息医学”,但68.4%的受访者不知道WHO对姑息治疗的定义(表2(135189))。在来自不同大学的所有学生中,33.3%的人表示姑息治疗是他们课程的一部分,而66.6%的人表示不是(表5(135192))。研究结果表明,在尼泊尔机构的本科医学生对姑息治疗的认识和认知不足。可将EAPC关于姑息治疗课程的指示作为一份蓝图,为尼泊尔医学院制定量身定制的课程,为下一代医生奠定坚实的基础,使他们能够适当地满足病人及其家属的需要。
{"title":"INTEGRATION OF PALLIATIVE CARE INTO MEDICAL SCHOOL CURRICULUM IN NEPAL – An analytical study among medical students in Nepal","authors":"Carlotta Bellon, T. Shah, A. Shah","doi":"10.53876/001c.68021","DOIUrl":"https://doi.org/10.53876/001c.68021","url":null,"abstract":"The holistic approach of palliative care aims at improving the life of patients with life-threatening diseases and their families through early identification, assessment, and treatment of physical, psychological, or spiritual pain. Despite the recognition of palliative care as a human right and essential for the improvement of the quality of life of patients – and their families, many low-income countries either lack palliative care services or have limited access to it. The WHO suggests that one of the steps that countries can take to eliminate these barriers is to include palliative care into the core curricula of all new health professionals. A study in 2019 showed that 58,000 adults required palliative care in Nepal in 2012, and most of them lived in rural areas. Palliative care in Nepal is still new and training programs for doctors and nurses are not fully developed and in place in undergraduate medical schools. This study evaluates the working knowledge of palliative care among undergraduate medical students, and the presence of it in their academic curriculum. This analytical study was designed during an internship at the Binaytara Foundation Cancer Center in Nepal. The study was conducted among undergraduate medical students between March 6th, 2020 to July 6th, 2020. The questionnaire results were entered on Microsoft Excel and then analyzed. Results showed that 63.2% of the respondents had heard of “Palliative Medicine”, but 68.4% did not know the WHO definition of Palliative Care (Table 2 (135189)). Among all the students from the different universities, 33.3% said that palliative care is part of their curriculum, while 66.6% said it is not (Table 5 (135192)). The results from the study demonstrated inadequate knowledge and perception of palliative care among undergraduate medical students in Nepali institutions. The EAPC indications on a palliative care curriculum could be taken as a blueprint for developing a tailored one for medical schools in Nepal to set a strong base for the next generation of doctors to be able to appropriately meet the needs of patients and their families.","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"422 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126710756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expenditure and Utilization Patterns of Cancer Care in Kuwait 科威特癌症治疗的支出和利用模式
Pub Date : 2022-11-11 DOI: 10.53876/001c.55511
S. Abuhadida, S. Alzaid, Yousef Buresli, Ahmad Alnusif, Barrak Alhindal
Cancer is among the leading causes of morbidity and mortality worldwide. However. The trends in utilization of cancer services and related expenditures in Kuwait are poorly known. We aim to investigate the expenditure and utilization patterns of cancer care in Kuwait. A three-year retrospective analysis study of expenditure and utilization pattern in KCCC was performed from 2015 to 2017 in MOH in Kuwait. We report a considerable variation of utilizations and expenditure levels over the three-year period. After adjusting the data, there was significant increase in utilization rates and expenditure in 2015-16 followed by significant decrease in year 2016-17. The expenditure was observed to increase by 1.1% in 2016 before it declined by 1.9% in 2017. This study is the first of its kind in Kuwait. We report adequate utilization and expenditure of cancer care in Kuwait. However, we recommend heavy investments in precision medicine technology and patient outcomes research to improve overall financial and operational performance pertaining to cancer care in MOH in Kuwait.
癌症是全世界发病率和死亡率的主要原因之一。然而。科威特利用癌症服务和相关支出的趋势鲜为人知。我们的目的是调查科威特癌症护理的支出和利用模式。2015年至2017年,科威特卫生部对KCCC的支出和利用模式进行了为期三年的回顾性分析研究。我们报告说,三年期间的利用和支出水平有相当大的变化。调整数据后,2015-16年的利用率和支出显著增加,2016-17年显著下降。2016年的支出增长了1.1%,2017年下降了1.9%。这项研究在科威特尚属首次。我们报告充分利用和支出的癌症护理在科威特。然而,我们建议在精准医疗技术和患者结果研究方面进行大量投资,以改善科威特卫生部癌症护理的整体财务和运营绩效。
{"title":"Expenditure and Utilization Patterns of Cancer Care in Kuwait","authors":"S. Abuhadida, S. Alzaid, Yousef Buresli, Ahmad Alnusif, Barrak Alhindal","doi":"10.53876/001c.55511","DOIUrl":"https://doi.org/10.53876/001c.55511","url":null,"abstract":"Cancer is among the leading causes of morbidity and mortality worldwide. However. The trends in utilization of cancer services and related expenditures in Kuwait are poorly known. We aim to investigate the expenditure and utilization patterns of cancer care in Kuwait. A three-year retrospective analysis study of expenditure and utilization pattern in KCCC was performed from 2015 to 2017 in MOH in Kuwait. We report a considerable variation of utilizations and expenditure levels over the three-year period. After adjusting the data, there was significant increase in utilization rates and expenditure in 2015-16 followed by significant decrease in year 2016-17. The expenditure was observed to increase by 1.1% in 2016 before it declined by 1.9% in 2017. This study is the first of its kind in Kuwait. We report adequate utilization and expenditure of cancer care in Kuwait. However, we recommend heavy investments in precision medicine technology and patient outcomes research to improve overall financial and operational performance pertaining to cancer care in MOH in Kuwait.","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125618730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic mutation profile in HER2 positive lobular breast cancer HER2阳性小叶型乳腺癌的基因突变谱
Pub Date : 2022-10-20 DOI: 10.53876/001c.38884
Suman Gaire, P. Budhathoki, U. Joshi, A. Shah, S. Yadav, S. Yadav
{"title":"Genetic mutation profile in HER2 positive lobular breast cancer","authors":"Suman Gaire, P. Budhathoki, U. Joshi, A. Shah, S. Yadav, S. Yadav","doi":"10.53876/001c.38884","DOIUrl":"https://doi.org/10.53876/001c.38884","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130029243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer Treated with Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices 评价使用Trilaciclib治疗的大分期小细胞肺癌患者化疗诱导的骨髓抑制:佛罗里达社区肿瘤学实践的回顾性分析
Pub Date : 2022-10-12 DOI: 10.53876/001c.38337
L. Hart, A. Ogbonnaya, Kristen Boykin, K. DeYoung, Ray Bailey, Trevor W. Heritage, L. Lopez-Gonzalez, Huan Huang, L. Gordan
{"title":"Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer Treated with Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices","authors":"L. Hart, A. Ogbonnaya, Kristen Boykin, K. DeYoung, Ray Bailey, Trevor W. Heritage, L. Lopez-Gonzalez, Huan Huang, L. Gordan","doi":"10.53876/001c.38337","DOIUrl":"https://doi.org/10.53876/001c.38337","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115842334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with ES- SCLC in US Community Oncology Settings 美国社区肿瘤环境中ES- SCLC患者Trilaciclib的使用和化疗诱导的骨髓抑制
Pub Date : 2022-10-12 DOI: 10.53876/001c.38340
J. Goldschmidt, A. Monnette, Pingan Shi, Divea Venkatasetty, L. Lopez-Gonzalez, Huan Huang, P. Conkling
{"title":"Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with ES- SCLC in US Community Oncology Settings","authors":"J. Goldschmidt, A. Monnette, Pingan Shi, Divea Venkatasetty, L. Lopez-Gonzalez, Huan Huang, P. Conkling","doi":"10.53876/001c.38340","DOIUrl":"https://doi.org/10.53876/001c.38340","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116573781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Non-Small Cell Lung Cancer (NSCLC) 评价不确定电位克隆造血(CHIP)在非小细胞肺癌(NSCLC)中的临床意义
Pub Date : 2022-10-12 DOI: 10.53876/001c.38199
Mason Alford, Candace J. Grisham, C. Thompson, W. Iams
{"title":"Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Non-Small Cell Lung Cancer (NSCLC)","authors":"Mason Alford, Candace J. Grisham, C. Thompson, W. Iams","doi":"10.53876/001c.38199","DOIUrl":"https://doi.org/10.53876/001c.38199","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131615263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating Tumor Cell cluster phenotype and response to treatment and predicts survival in lung cancer 循环肿瘤细胞簇表型和对治疗的反应,并预测肺癌的生存
Pub Date : 2022-10-12 DOI: 10.53876/001c.38332
G. Kanakasetty, Priadarshini Kumar, A. Rangarajan
{"title":"Circulating Tumor Cell cluster phenotype and response to treatment and predicts survival in lung cancer","authors":"G. Kanakasetty, Priadarshini Kumar, A. Rangarajan","doi":"10.53876/001c.38332","DOIUrl":"https://doi.org/10.53876/001c.38332","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"22 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120859840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of genetic alterations of DNA repair genes as prognostic marker of survival in cholangiocarcinoma 胆管癌患者DNA修复基因基因改变作为预后标志物的分析
Pub Date : 2022-10-12 DOI: 10.53876/001c.38333
U. Joshi, S. Yadav, Roshan Subedi, Nira Neupane, P. Budhathoki, Suman Gaire, A. Shah, Aashish Acharya, V. Agrawal, S. Yadav
{"title":"Analysis of genetic alterations of DNA repair genes as prognostic marker of survival in cholangiocarcinoma","authors":"U. Joshi, S. Yadav, Roshan Subedi, Nira Neupane, P. Budhathoki, Suman Gaire, A. Shah, Aashish Acharya, V. Agrawal, S. Yadav","doi":"10.53876/001c.38333","DOIUrl":"https://doi.org/10.53876/001c.38333","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126349280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serial Monitoring of circulating tumor DNA (ctDNA) reliably detects progression and regression in lung cancer patients 循环肿瘤DNA (ctDNA)的连续监测可靠地检测肺癌患者的进展和消退
Pub Date : 2022-10-06 DOI: 10.53876/001c.38336
Ujjwal Karki, B. Ghimire, Emma Herrman, M. Chisti
{"title":"Serial Monitoring of circulating tumor DNA (ctDNA) reliably detects progression and regression in lung cancer patients","authors":"Ujjwal Karki, B. Ghimire, Emma Herrman, M. Chisti","doi":"10.53876/001c.38336","DOIUrl":"https://doi.org/10.53876/001c.38336","url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116848664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States COVID-19大流行期间癌症筛查中的种族和种族不平等:美国的一项多地点观察性研究
Pub Date : 2022-08-23 DOI: 10.53876/001c.37412
D. Idossa, H. Borno, Katarina Wang, M. Pletcher, G. Gresham, A. Canchola, D. Bell, M. Matheny, Lisa M Schilling, A. Perkins, Kai Zheng, L. Ohno-Machado, Jihoon Kim, S. SooHoo, D. Meeker, Scarlett L. Gomez
The total impact of the current COVID-19 pandemic on cancer screenings and diagnostic procedures by race and ethnicity has not yet been fully characterized. In this study, we compared the ethnic and racial differences in cancer screening for breast, colon, and prostate cancer and compared them to population-level SARS-CoV2 infection rates in the United States between January 2019 and January 2021. A significant reduction in all screening activities was observed between March and May of 2020, with the largest relative decline in April during the initial SARS-CoV2 surge. In that month, screening mammography declined by 80% overall, with the relative largest decline among Black individuals (90%). A higher proportion of Black individuals received diagnostic mammography in April 2020. However, between June 2020 and January 2021, there was a relative increase in diagnostic mammograms observed across all groups. There was also a relative reduction in colon cancer screening, with the largest decline in April 2020 among Black individuals (75%). The largest relative reduction in PSA screening was in Hispanic individuals (66%). During the examined study period, surgical resections for breast, colon, and prostate resections were reduced and remained lower than baseline through 2020. The reduction in breast, colon, and prostate cancer screening coincided with the first surge of the SARS-CoV2 infections, but not with the second. There was a small reduction in breast and colon cancer screening with the third surge. Differential inequities in cancer screening and diagnoses were observed by race and ethnicity and corresponded primarily to the initial surge of SARS-CoV2.
目前的COVID-19大流行对按种族和族裔划分的癌症筛查和诊断程序的总体影响尚未得到充分描述。在这项研究中,我们比较了乳腺癌、结肠癌和前列腺癌筛查中的种族和种族差异,并将其与2019年1月至2021年1月期间美国人口水平的SARS-CoV2感染率进行了比较。在2020年3月至5月期间,所有筛查活动都显着减少,在SARS-CoV2最初激增期间的4月相对下降幅度最大。当月,乳房x光检查总体下降了80%,其中黑人下降幅度最大(90%)。2020年4月,接受诊断性乳房x光检查的黑人比例更高。然而,在2020年6月至2021年1月期间,在所有组中观察到的诊断性乳房x光检查相对增加。结肠癌筛查也相对减少,黑人在2020年4月下降幅度最大(75%)。PSA筛查相对减少最多的是西班牙裔个体(66%)。在研究期间,乳房、结肠和前列腺切除术的手术切除减少,到2020年仍低于基线。乳腺癌、结肠癌和前列腺癌筛查的减少与SARS-CoV2感染的第一次激增同时发生,但与第二次激增无关。在第三次激增中,乳腺癌和结肠癌的筛查略有减少。根据种族和民族观察到癌症筛查和诊断方面的差异不平等,这主要与SARS-CoV2的初始激增有关。
{"title":"Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States","authors":"D. Idossa, H. Borno, Katarina Wang, M. Pletcher, G. Gresham, A. Canchola, D. Bell, M. Matheny, Lisa M Schilling, A. Perkins, Kai Zheng, L. Ohno-Machado, Jihoon Kim, S. SooHoo, D. Meeker, Scarlett L. Gomez","doi":"10.53876/001c.37412","DOIUrl":"https://doi.org/10.53876/001c.37412","url":null,"abstract":"The total impact of the current COVID-19 pandemic on cancer screenings and diagnostic procedures by race and ethnicity has not yet been fully characterized. In this study, we compared the ethnic and racial differences in cancer screening for breast, colon, and prostate cancer and compared them to population-level SARS-CoV2 infection rates in the United States between January 2019 and January 2021. A significant reduction in all screening activities was observed between March and May of 2020, with the largest relative decline in April during the initial SARS-CoV2 surge. In that month, screening mammography declined by 80% overall, with the relative largest decline among Black individuals (90%). A higher proportion of Black individuals received diagnostic mammography in April 2020. However, between June 2020 and January 2021, there was a relative increase in diagnostic mammograms observed across all groups. There was also a relative reduction in colon cancer screening, with the largest decline in April 2020 among Black individuals (75%). The largest relative reduction in PSA screening was in Hispanic individuals (66%). During the examined study period, surgical resections for breast, colon, and prostate resections were reduced and remained lower than baseline through 2020. The reduction in breast, colon, and prostate cancer screening coincided with the first surge of the SARS-CoV2 infections, but not with the second. There was a small reduction in breast and colon cancer screening with the third surge. Differential inequities in cancer screening and diagnoses were observed by race and ethnicity and corresponded primarily to the initial surge of SARS-CoV2.","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124045905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Cancer Care and Delivery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1